Related content

A new series of potent oxindole inhibitors of CDK2

By Luk K.-C.   Simcox M.E.   Schutt A.   Rowan K.   Thompson T.   Chen Y.   Kammlott U.   DePinto W.   Dunten P.   Dermatakis A.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 4, 2004-02 ,pp. : 913-917

Elsevier

Access to resources Recommend Favorite

ABCG2: recent discovery of potent and highly selective inhibitors

By Lecerf-Schmidt Florine   Peres Basile   Valdameri Glaucio   Gauthier Charlotte   Winter Evelyn   Payen Léa   Di Pietro Attilio   Boumendjel Ahcène  

Future Medicinal Chemistry, Vol. 5, Iss. 9, 2013-06 ,pp. : 1037-1045

Future Science

Access to resources Recommend Favorite

Synthesis of potent and selective 2-azepanone inhibitors of human tryptase

By Zhao G.   Bolton S.A.   Kwon C.   Hartl K.S.   Seiler S.M.   Slusarchyk W.A.   Sutton J.C.   Bisacchi G.S.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 2, 2004-01 ,pp. : 309-312

Elsevier

Access to resources Recommend Favorite

Peptidomimetic 2-cyanopyrrolidines as potent selective cathepsin L inhibitors

By Yadav Mange   Shinde Anil   Chouhan Bishram   Giridhar Rajani   Menard Robert  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 23, Iss. 2, 2008-04 ,pp. : 190-197

Informa Healthcare

Access to resources Recommend Favorite

Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors

By Lau C.K.   Bayly C.I.   Gauthier J.Y.   Li C.S.   Therien M.   Asante-Appiah E.   Cromlish W.   Boie Y.   Forghani F.   Desmarais S.   Wang Q.   Skorey K.   Waddleton D.   Payette P.   Ramachandran C.   Kennedy B.P.   Scapin G.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 4, 2004-02 ,pp. : 1043-1048

Elsevier

Access to resources Recommend Favorite